Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP325993.RAXvJ2iBV-JhEXoj-vuJzoCXI2X1gfeDKOb2sNcR4H5hg130_assertion description "[Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325993.RAXvJ2iBV-JhEXoj-vuJzoCXI2X1gfeDKOb2sNcR4H5hg130_provenance.
• NP258094.RAiPvv8GZYFgQ2h8shsbPv9-QK8VoXmSvtZeFFofX8xEE130_assertion description "[Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP258094.RAiPvv8GZYFgQ2h8shsbPv9-QK8VoXmSvtZeFFofX8xEE130_provenance.
• NP173960.RAkOYY6s0xGyjRm5oVgLvrs5bbsSEe8ejUhQ2GgrJnp-Q130_assertion description "[Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP173960.RAkOYY6s0xGyjRm5oVgLvrs5bbsSEe8ejUhQ2GgrJnp-Q130_provenance.
• NP489720.RApPI7TeGeznJgWU3wkTOu2N5n5dJAOjfwXJ5m068KzxY130_assertion description "[Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP489720.RApPI7TeGeznJgWU3wkTOu2N5n5dJAOjfwXJ5m068KzxY130_provenance.
• NP591167.RAkAZqeWfL_MexmR_sZsbiRJAMUP2tlFj379xSbi-TTRI130_assertion description "[Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591167.RAkAZqeWfL_MexmR_sZsbiRJAMUP2tlFj379xSbi-TTRI130_provenance.
• NP378173.RAWcUvvs0Ipjjgx02gsw2DkU58ni8iLxiUGHyoJ1DUjW0130_assertion description "[Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378173.RAWcUvvs0Ipjjgx02gsw2DkU58ni8iLxiUGHyoJ1DUjW0130_provenance.
• NP522951.RA3b_qvuoWINcNJ61mbyJZ_p0hZxMp2PtHZNEe3CRQ9VQ130_assertion description "[Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP522951.RA3b_qvuoWINcNJ61mbyJZ_p0hZxMp2PtHZNEe3CRQ9VQ130_provenance.
• NP615485.RA_nBo9px-C4alPh7aqplegacGzwEWxA_9RaugKjf_wSs130_assertion description "[Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615485.RA_nBo9px-C4alPh7aqplegacGzwEWxA_9RaugKjf_wSs130_provenance.
• NP299415.RANOqFYt027BCXPh9xXzNNjRtAyCLe1shf_3a43MGAIEc130_assertion description "[Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299415.RANOqFYt027BCXPh9xXzNNjRtAyCLe1shf_3a43MGAIEc130_provenance.
• NP577890.RAM3F3ZpkUCQpOnAQaoDq4DKQ1fLzleoItdz1FOYUFmlM130_assertion description "[Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577890.RAM3F3ZpkUCQpOnAQaoDq4DKQ1fLzleoItdz1FOYUFmlM130_provenance.
• NP766761.RAGbKGB76Y9Y7d5l8jFiPkcMmZnyGD49nkc1L3-235Pws130_assertion description "[Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766761.RAGbKGB76Y9Y7d5l8jFiPkcMmZnyGD49nkc1L3-235Pws130_provenance.